Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib
PaperCitations, authors & open-access status
Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 418 citations, 2019 year and bronze oa status.
418
Citations
2019
Year
bronze
OA Status